Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

NCT05262270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

427

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Use Disorder

Interventions

DRUG: Extended-Release Naltrexone
DRUG: Extended Release Buprenorphine
DRUG: Placebo (PLB) Injectable matched to XR-NTX
DRUG: Placebo (PLB) Injectable matched to XR-BUP

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]